When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national). If doubt exists whether the research was conducted in accordance with the ethical standards, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.
The manuscript must have been read and approved by all authors and that all authors agree to the submission of the manuscript to China Oncology. All authors should have made substantial contributions to all of the following:
● conception and design of the study, acquisition of the data, or analysis and interpretation of the data;
● drafting of the article or critical revision of the article for important intellectual content;
● final approval of the version to be submitted. When authorship is attributed to a group, all authors must meet the listed criteria and must be responsible for the quality, accuracy, and ethics of the work. All authors must participate in determining the order of authorship.
Conflict of interest and source of funding
China Oncology requires that all sources of institutional, private, and corporate financial support for the work within the manuscript must be fully acknowledged, and any potential conflicts of interest noted. Grant or contribution numbers may be acknowledged, and principal grant holders should be listed.
Submissions will be considered for publication in China Oncology only if they are submitted solely to China Oncology and do not overlap substantially with a published article. Any manuscript that has similar or near similar hypothesis, sample characteristics, methodology, results, and conclusions to a published article is a duplicate article and is prohibited.
The Ministry of Education of the People’s Republic of China
Fudan University Shanghai Cancer Center
Editorial Board of China Oncology
TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou
Shanghai Ouyang Printing Co., Ltd.